Semaglutide could benefit millions of Americans with obesity, heart disease
Semaglutide (brand name: Wegovy) has the potential to markedly reduce the risk of heart attacks and other heart-related conditions among millions of Americans with obesity who have also been diagnosed with cardiovascular ...
Nov 22, 2023
0
0